Cargando…

Increased intraocular inflammation in retinal vein occlusion is independent of circulating immune mediators and is involved in retinal oedema

We aim to understand the link between systemic and intraocular levels of inflammatory mediators in treatment-naïve retinal vein occlusion (RVO) patients, and the relationship between inflammatory mediators and retinal pathologies. Twenty inflammatory mediators were measured in this study, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yufan, Qi, Jinyan, Liu, Hengwei, Liang, Shengnan, Guo, Tingting, Chen, Juan, Pan, Wei, Tan, Huanhuan, Wang, Jie, Xu, Heping, Chen, Zhongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405077/ https://www.ncbi.nlm.nih.gov/pubmed/37554292 http://dx.doi.org/10.3389/fnins.2023.1186025

Ejemplares similares

Perifoveal Microcirculation in Macular Oedema with Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2012)

Inflammation in Retinal Vein Occlusion
por: Deobhakta, Avnish, et al.
Publicado: (2013)

Clinical characteristics of branch retinal vein occlusion with increased retinal haemorrhage during treatment for macular oedema
por: Lee, You Hyun, et al.
Publicado: (2020)

Treatments for macular oedema following central retinal vein occlusion: systematic review
por: Ford, John A, et al.
Publicado: (2014)

Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion
por: Thom, Howard HZ, et al.
Publicado: (2014)

Branch Retinal Vein Occlusion followed by Central Retinal Vein Occlusion
por: Moradian, Siamak, et al.
Publicado: (2009)

Drug treatment of macular oedema secondary to central retinal vein occlusion: a network meta-analysis
por: Ford, John A, et al.
Publicado: (2014)

Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
por: Hikichi, Taiichi, et al.
Publicado: (2014)

Central retinal vein occlusion and branch retinal vein occlusion in the same eye
por: Sundar, M Dheepak, et al.
Publicado: (2019)

Retinal Macrophage-Like Cells as a Biomarker of Inflammation in Retinal Vein Occlusions
por: Maltsev, Dmitrii S., et al.
Publicado: (2022)

A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics
por: Wang, Bingjie, et al.
Publicado: (2022)

Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review
por: Glanville, Julie, et al.
Publicado: (2014)

A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion
por: Ang, Juan Lyn, et al.
Publicado: (2020)

Comment on: Ranibizumab and aflibercept intravitreal injection for treatment naïve and refractory macular oedema in branch retinal vein occlusion
por: Elkazza, Sumeia A, et al.
Publicado: (2020)

Long-term outcomes for patients treated for macular oedema secondary to retinal vein occlusion: a systematic review
por: Hunter, Alexandra, et al.
Publicado: (2022)

Combined central retinal vein occlusion and branch retinal artery occlusion
por: Goel, Sugandha, et al.
Publicado: (2018)

Retinal vein occlusions: The potential impact of a dysregulation of the retinal veins
por: Fraenkl, Stephan A., et al.
Publicado: (2010)

The Impact of Intraocular Treatment on Visual Acuity of Patients Diagnosed with Branch Retinal Vein Occlusions
por: Darabuş, Diana-Maria, et al.
Publicado: (2023)

Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety
por: Mishra, S. K., et al.
Publicado: (2018)

Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
por: Konidaris, Vasileios E., et al.
Publicado: (2018)

Real-World Evidence for Treat-and-Extend Regimen of Ranibizumab Therapy for Macular Oedema Secondary to Branch Retinal Vein Occlusion
por: Rodríguez-Fernández, Carmen Antía, et al.
Publicado: (2022)

Short-term and long-term results after intravitreal bevacizumab therapy for macular oedema in branch retinal vein occlusion
por: Pidro, Ajla, et al.
Publicado: (2022)

Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis
por: Xu, Shanshan, et al.
Publicado: (2022)

Real-world outcomes of intravitreal bevacizumab treat-and-extend for cystoid macular oedema secondary to central retinal vein occlusion
por: Gildea, David, et al.
Publicado: (2023)

Concurrent central retinal artery occlusion and branch retinal vein occlusion in giant cell arteritis
por: Chu, Edward R, et al.
Publicado: (2010)

Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion
por: Cho, Bum-Joo, et al.
Publicado: (2019)

Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
por: Fortunato, Pina, et al.
Publicado: (2009)

Acute macular neuroretinopathy with coexistent central retinal vein occlusion as the presenting feature in intraocular tuberculosis
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

A narrative review on the association of high intraocular pressure and glaucoma in patients with retinal vein occlusion
por: Jabbehdari, Sayena, et al.
Publicado: (2022)

Practical Management of Retinal Vein Occlusions
por: La Spina, Carlo, et al.
Publicado: (2012)

Dexamethasone implant in retinal vein occlusions
por: Han, Sang Beom, et al.
Publicado: (2016)

Neurodegeneration in branch retinal vein occlusion
por: Alshareef, Rayan A., et al.
Publicado: (2016)

Retinal artery and vein occlusion in calciphylaxis
por: Naranjo, Andrea, et al.
Publicado: (2022)

Comparative efficacy and safety of approved treatments for macular oedema secondary to branch retinal vein occlusion: a network meta-analysis
por: Regnier, Stephane A, et al.
Publicado: (2015)

Combination Therapy for Macular Oedema in Retinal Vein Occlusions: 3-Year Results from a Real-World Clinical Practice
por: Horner, Faye, et al.
Publicado: (2020)

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion
por: Bhandari, Sanjeeb, et al.
Publicado: (2022)

12‐month outcomes of ranibizumab versus aflibercept for macular oedema in central retinal vein occlusion: data from the FRB! registry
por: Niedzwiecki, Mateusz, et al.
Publicado: (2021)

Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion
por: Modi, Yasha S., et al.
Publicado: (2023)

Combined central retinal artery occlusion and vein occlusion with exudative retinal detachment following COVID‐19 vaccination
por: Chen, Yen‐Chih
Publicado: (2022)

Retinal Vessel Phenotype in Patients with a History of Retinal Vein Occlusion
por: Semecas, Rachel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oh778n6r9p2vpkua88v0i6i9jo